Markets & Economy
AMETEK posts record Q4 and 2025 results, accelerates M&A and medical device push in the U.S.
AMETEK closed 2025 with record revenue, orders, margins, and cash generation, driven by broad strength across electronic instruments, electromechanical businesses and targeted acquisitions. Management signaled a disciplined, acquisitive 2026 plan with mid-single-digit organic growth guidance, margin expansion, and increased investment in med-tech and defense adjacencies.
